A randomized controlled trial in healthy participants to compare the insulinogenic effects of whey protein and pea protein co-ingested with glucose
Thondre PS, Young E, Pledger S, Kefyalew S, Hatami I, Perreau C, Guérin Deremaux L, Lefranc-Millot C, Tammam J
PloS one · 30. ledna 2026
ABSTRAKT AUTORŮ
Increasing protein content of foods is effective in reducing postprandial hyperglycaemia, but animal protein may exacerbate insulin sensitivity. This single-blind, randomised, crossover study compared the effects of co-ingesting glucose with 10 or 20 g whey protein and glucose with 10 or 20 g pea protein, with a reference product (glucose) on glycaemic and insulinaemic responses in 30 healthy individuals. Blood glucose and plasma insulin were measured at baseline, 15, 30, 45, 60, 90, 120, 150 and 180 minutes after product consumption. The trial was registered with Clinical Trials.gov (NCT04871971). Glucose incremental area under the curve (mmol/l*min) at 180 minutes was significantly reduced (p < 0.001) for glucose with 20 g pea protein (89.8 ± 51.6) and glucose with 20g whey protein (98.5 ± 58.0) compared to glucose (143.2 ± 74.0). Insulin incremental area under the curve at 180 minutes (µU/ml*min) for glucose with 20 g pea protein (4304.56 ± 1896.07) was significantly lower (p < 0.001) than glucose with 20g whey protein (6311.81 ± 3489.12). This study has shown a superior effect of pea protein over whey protein in reducing glycaemic response, without any excessive increase in insulinaemic response.
Původní abstrakt, převzatý beze změn. © Autoři, šířeno pod licencí Creative Commons CC BY. Přesné podmínky jsou uvedeny v původním článku.
Vědecké informace; nenahrazují radu zdravotnického pracovníka. Přítomnost studie v této knihovně nepředstavuje tvrzení o našich produktech.
← Všechny studie